Global Study Manager | Clinical Trial Lead (25% Travel)

ICON Clinical Research; United Kingdom; À distance; GBP 75 000 - 120 000; Plein temps

Avantages offerts par ce poste

Annual leave

Health insurance

Retirement plan

Global EAP LifeWorks

Life assurance

Flexible benefits

Résumé du poste

ICON Strategic Solutions is seeking a Global Study Manager to lead day-to-day clinical trial management activities across our sponsor-dedicated model. You will guide teams to deliver quality outcomes and collaborate with investigators to ensure compliance and timely delivery of programs.

The role emphasizes stakeholder engagement, protocol implementation, and risk management, with travel approximately 25% and a focus on delivering treatment advances for patients worldwide.

Qualifications

• Solid clinical trial management experience.
• Ability to drive the clinical deliverables of a study.
• Strong subject matter expertise in the designated therapeutic area.
• Prior monitoring experience is a plus.
• Willingness to travel approximately 25%.

Responsabilités

• Plan and manage all aspects of clinical trials, ensuring timelines, budget, and quality.
• Collaborate with cross-functional teams to establish and implement trial protocols.
• Build and manage relationships with trial investigators and stakeholders.
• Ensure trials comply with regulations and ethical guidelines.
• Problem-solve and make decisions on trial design, vendor selection, and risk management.

Connaissances

Clinical trial management

Team leadership

Stakeholder management

Willingness to travel

Formation

University degree in medicine, science, or equivalent

Description du poste

ICON Strategic Solutions is seeking a Global Study Manager to lead day-to-day clinical trial management activities across our sponsor-dedicated model. You will guide teams to deliver quality outcomes and collaborate with investigators to ensure compliance and timely delivery of programs.

The role emphasizes stakeholder engagement, protocol implementation, and risk management, with travel approximately 25% and a focus on delivering treatment advances for patients worldwide.